Status: Recruiting
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
Previous studies have confirmed the great potential of quantitative fluorescence molecular endoscopy (qFME) when looking at additional lesion detection initially missed by high-definition white light endoscopy (HD-WLE) for surveillance of Barrett's esophagus.
Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University Medical Center GroningenUpdated: Apr 13, 2026Locations: 1
Eligibility criteria
BE patients without dysplasia and with suspected/diagnosed low-grade dysplasia (... [+1]
Patients under the age of eighteen. [+7]